en
Scientific article
English

Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro

Published inBoneKEy reports, vol. 4, no. Art. 757
Publication date2015
Citation (ISO format)
THOUVEREY, Cyril, CAVERZASIO, Joseph. Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro. In: BoneKEy reports, 2015, vol. 4, n° Art. 757. doi: 10.1038/bonekey.2015.126
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2047-6396
401views
7downloads

Technical informations

Creation01/15/2016 9:55:00 AM
First validation01/15/2016 9:55:00 AM
Update time03/15/2023 12:10:22 AM
Status update03/15/2023 12:10:22 AM
Last indexation01/16/2024 8:19:38 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack